CRISPR Therapeutics AG(CRSP)NASDAQ
Fundamental Analysis & Financials
Valuation Snapshot
What the multiples imply about expectations
The market considers the company to be a smaller player with a significant market presence. At current multiples, it trades attractively valued—reflecting market expectations.
Valuation Metrics
Ratios and multiples
Financial Health
Liquidity and leverage
The company's financial health appears moderate. Moderate ROE and moderate ROA reflect reasonably efficient capital use. Debt is elevated but represents structural leverage for shareholder return strategy (buybacks) rather than operational stress.
Valuation Multiples
Current valuation metrics
Quarterly Earnings History
Recent quarterly financial performance and trends
| Quarter | Revenue | Net Income | Gross Profit | EPS (Basic) | EPS (Diluted) | Gross Margin | Net Margin |
|---|---|---|---|---|---|---|---|
| Q2 2026(Latest) | $10.00M | $-91.15M | $-30.27M | $-0.94 | $-0.94 | N/A | -911.5% |
| Q1 2026 | $1.00M | $-122.93M | $-44.95M | $-1.28 | $-1.28 | N/A | -12293.1% |
| Q4 2025 | $0.00 | $-130.61M | $-53.70M | $-1.37 | $-1.37 | N/A | N/A |
| Q3 2025 | $0.00 | $-106.44M | $-57.12M | $-1.17 | $-1.17 | N/A | N/A |
| Q2 2025 | $0.00 | $-208.55M | $-45.15M | $-2.40 | $-2.40 | N/A | N/A |
| Q1 2025 | $0.00 | $-136.00M | $-57.51M | $-1.58 | $-1.58 | N/A | N/A |
Key Insights:
- Revenue increased by 900.0% from previous quarter
- Net margin of -911.5% indicates low profitability
- EPS improved by 26.6% quarter-over-quarter
Financial Efficiency
Utilization and collections performance
Asset Turnover 0.01 indicates low efficiency. Working Capital Turnover 0.01 is moderately efficient. ROIC -23.5% highlights weak capital returns.
Efficiency Metrics
Profitability & Growth
Margins and earnings power
Efficiency Performance Matrix
4-quadrant analysis of operational efficiency vs profitability
Efficiency vs Profitability Quadrants
High Margin
Low Margin
High Margin
Low Margin
Efficiency Analysis
Asset Turnover
Receivables Turnover
Working Capital
Overall Efficiency Score
Operationally weak with structural efficiency and margin issues
⚠️ Thresholds are benchmark-based heuristics derived from long-term industry averages, not strict valuation rules.
• Bubble size represents ROIC magnitude
• Green (Optimal): Excellent efficiency-profitability balance
• Blue (Efficiency-Driven): High turnover, room to improve margins
• Yellow (Margin-Driven): Strong margins, opportunity to improve efficiency
• Red (Weak Operations): Areas needing improvement on both dimensions
Market Data & Share Structure
Comprehensive valuation metrics and ownership breakdown
Market Data & Capitalization
Share Statistics & Ownership
Profitability Margin Pyramid
Hierarchical view of margin compression from revenue to net income
Margin Hierarchy by Profitability Level
Margin Analysis
Total Revenue
Gross Profit
EBITDA
Net Income
Margin Quality Assessment
Thin margins indicating potential profitability challenges
• Larger circles represent higher dollar amounts
• Margin percentages show profitability at each level
• Blue: Revenue base
• Green: Gross profitability
• Yellow: Operating performance
• Red: Net profitability
Operating Cash & Liquidity
Core cash generation and short-term solvency
Cash Flow Analysis
Operating Cash Flow (TTM)
$-369.58M
Cash from core operations
Free Cash Flow (TTM)
$-215.85M
Available after capex
Financial Position & Liquidity
Current Ratio
17.85
Healthy
Quick Ratio
17.79
Strong
Net Cash
$1.58B
Net creditor
Total Cash
$2.36B
Balance sheet cash
Total Debt
$783.75M
Outstanding borrowings
Ownership & Shareholder Sentiment
Insider, institutional, and short interest positions
Insider Ownership
5.89%
Moderate stake
Institutional Ownership
79.42%
Majority backing
Short % of Float
22.97%
Heavy bearish
Short Ratio (Days)
11.3d
days to cover
Ownership structure shows strong insider confidence and institutional majority backing.
Dividends & Shareholder Returns
Policy stance and implications
The company does not currently pay a regular dividend — prioritizing reinvestment for growth. This makes it attractive for growth investors, while income-oriented investors may prefer peers with dividend payouts.
Explore More Analysis for CRSP
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.